Amphotericin B (X-GEN Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Amphotericin B drug offered from X-GEN Pharmaceuticals, Inc.. This Lipid-based Polyene Antifungal [EPC],Polyene Antifungal [EPC],Polyenes [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: X-GEN Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: Amphotericin B
SUBSTANCE NAME: AMPHOTERICIN B
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Lipid-based Polyene Antifungal [EPC],Polyene Antifungal [EPC],Polyenes [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1992-04-29
END MARKETING DATE: 0000-00-00


Amphotericin B HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAmphotericin B from X-GEN Pharmaceuticals, Inc.
LABELER NAME: X-GEN Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/10mL)
START MARKETING DATE: 1992-04-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 39822-1055_234d7e4f-dc71-488d-a694-aec1775496aa
PRODUCT NDC: 39822-1055
APPLICATION NUMBER: ANDA063206

Other AMPHOTERICIN B Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Astellas Pharma US, Inc.AmBisome
X-GEN Pharmaceuticals, Inc.Amphotericin B